Back

Coronacept - a potent immunoadhesin against SARS-CoV-2

Cohen-Dvashi, H.; Weinstein, J.; Katz, M.; Eilon, M.; Mor, Y.; Shimon, A.; Strobelt, R.; Shemesh, M.; Fleishman, S. J.; Diskin, R.

2020-08-12 bioengineering
10.1101/2020.08.12.247940 bioRxiv
Show abstract

Angiotensin-converting enzyme 2 (ACE2) is the cellular receptor for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Computational analysis of mammalian ACE2 orthologues suggests various residues at the interface with the viral receptor binding domain that could facilitate tighter interaction compared to the human-ACE2. Introducing several mutations to the human-ACE2 resulted with significantly augmented affinity to the viral spike complex. This modified human-ACE2 fused to an Fc portion of an antibody makes a potent immunoadhesin that effectively targets SARS-CoV-2.

Matching journals

The top 7 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.